PMC:7784829 / 409-839 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T9","span":{"begin":8,"end":149},"obj":"Sentence"},{"id":"T10","span":{"begin":150,"end":259},"obj":"Sentence"},{"id":"T11","span":{"begin":260,"end":364},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"e cell. Both the viruses enter the host cell by binding of the viral spike glycoprotein to the host receptor, angiotensin converting enzyme 2 (ACE2). Targeting entry of the virus has a better advantage than inhibiting the later stages of the viral life cycle. The crystal structure of the SARS-CoV (6CRV: full length S protein) and SARS-CoV-2 Spike proteins (6M0J: Receptor binding domain, RBD) was used to determine potential sma"}

{"project":"LitCovid-PubTator","denotations":[{"id":"23","span":{"begin":110,"end":141},"obj":"Gene"},{"id":"24","span":{"begin":143,"end":147},"obj":"Gene"},{"id":"27","span":{"begin":343,"end":348},"obj":"Gene"},{"id":"32","span":{"begin":289,"end":297},"obj":"Species"},{"id":"33","span":{"begin":332,"end":342},"obj":"Species"}],"attributes":[{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Gene:59272"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Gene:59272"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"Gene:43740568"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Tax:694009"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e cell. Both the viruses enter the host cell by binding of the viral spike glycoprotein to the host receptor, angiotensin converting enzyme 2 (ACE2). Targeting entry of the virus has a better advantage than inhibiting the later stages of the viral life cycle. The crystal structure of the SARS-CoV (6CRV: full length S protein) and SARS-CoV-2 Spike proteins (6M0J: Receptor binding domain, RBD) was used to determine potential sma"}